These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30811275)

  • 1. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview.
    Vivas R; Barbosa AAT; Dolabela SS; Jain S
    Microb Drug Resist; 2019; 25(6):890-908. PubMed ID: 30811275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.
    Bharadwaj A; Rastogi A; Pandey S; Gupta S; Sohal JS
    Biomed Res Int; 2022; 2022():5419874. PubMed ID: 36105930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for multidrug-resistant bacteria.
    Giamarellou H
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):601-18. PubMed ID: 17009940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections.
    File TM; Jump RLP; Goff DA
    Infect Dis Clin North Am; 2020 Dec; 34(4):903-920. PubMed ID: 33131574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant organisms and antibiotic management.
    Barie PS
    Surg Clin North Am; 2012 Apr; 92(2):345-91, ix-x. PubMed ID: 22414417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of multi-drug-resistance in hepatology.
    Fernández J; Bert F; Nicolas-Chanoine MH
    J Hepatol; 2016 Nov; 65(5):1043-1054. PubMed ID: 27544545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.
    Obolski U; Stein GY; Hadany L
    PLoS Comput Biol; 2015 Jun; 11(6):e1004340. PubMed ID: 26110266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics Therapy in the Multi-Resistant Patient.
    Blanco-Nistal MM; Fernández-Fernández JA
    Methods Mol Biol; 2021; 2296():423-439. PubMed ID: 33977463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
    Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
    BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
    Cerceo E; Deitelzweig SB; Sherman BM; Amin AN
    Microb Drug Resist; 2016 Jul; 22(5):412-31. PubMed ID: 26866778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.
    Reddy P; Chadaga S; Noskin GA
    J Hosp Med; 2009 Jul; 4(6):E8-15. PubMed ID: 19670375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
    Eom SH; Kim YM; Kim SK
    Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.